Nonalcoholic fatty liver disease is the most prevalent liver disease worldwide, affecting 20%–
25% of the adult population. In 25% of patients, nonalcoholic fatty liver disease progresses …

Although fibrosis is a final pathological feature of many chronic diseases, few interventions
are available that specifically target the pathogenesis of fibrosis. Natural products are …

Liver disease remains a leading cause of mortality worldwide despite recent successes in
the field of viral hepatitis, because increases in alcohol consumption and obesity are fuelling …

Liver cancer is the second most frequent cause of cancer-related death globally. The main
histological subtype is hepatocellular carcinoma (HCC), which is derived from hepatocytes …

Alcohol-associated liver disease (ALD) and its complications are significant health problems
worldwide. Several pathways in ALD are influenced by alcohol that drives inflammation, fatty …

Abstract The Hedgehog (Hh) signalling pathway plays a critical role in regulating liver lipid
metabolism and related diseases. However, the underlying mechanisms are poorly …

Objective High-fat diet (HFD) and inflammation are two key contributors to nonalcoholic fatty
liver disease (NAFLD). Shenling Baizhu powder (SLBZP), a classical herbal compound, has …

Background Non-alcoholic fatty liver disease (NAFLD) has emerged as a burgeoning health
problem worldwide, but no specific drug has been approved for its treatment. Shenling …

Non-alcoholic fatty liver disease (NAFLD) derives from the accumulation of hepatic lipids,
which leads to liver steatosis and then triggers non-alcoholic steatohepatitis, sometimes …

Fatty liver is one of the most pervasive liver diseases worldwide. Probiotics play an important
role in the progression of liver disease, but their effects on host regulation are poorly …